Our hospitals were hit by a Pandemic before nursing shortages were a problem. Two years of overloading systems have contributed to stress and other factors that plague the people we rely on for our own well-being. We've seen robotic applications to just about every other field, so why not nursing, a field that will require one million new faces to keep up with demand in the U.S. alone?
Diligent has been leading that charge for a while now. The impact the past two years have had on the company was discussed in a late last year conversation. She noted in part.
It is really just a dramatic shift in labor markets across a lot of different industries. It seems to be related both to people kind of having a great resignation, where people are deciding that they want to do different things. And a lot of people shifting jobs. We’re seeing that all across tech work, a lot in our industry and healthcare. A lot of people are just deciding to do something else. There were already workforce challenges pre-pandemic, and now those are reaching crisis levels.
Diligent scored $10 million in the last funding round in March of 2020. The company announced this week that it was doubling the amount for a Series N to $30 million. Tiger Global, which seems to have its striped paws in all things robotic funding, led the round. Cedars-Sinai Health Ventures joined in, along with existing investors True Venture, DNX Venture, E14 Fund, Next Coast Venture, Boom Capital and Gaingels.
This new round of funding will help us scale the company to meet the incredible demand for our healthcare service robot, according to a release tied to today's news. We are focused on expanding automated support for clinical teams so nurses and clinicians can focus on tasks that matter most to patients.
Diligent will use the funding to help navigate some supply chain issues as it continues to deploy its nurse assisting bot, Moxie. The startup has just under $50 million in funding.
All Rights Reserved © 2024
